Bioanalytical Systems (BASI) Swings to Q3 Loss

Bioanalytical Systems (NASDAQ: BASI) reported Q3 EPS of ($0.05), versus $0.16 reported last year. Revenue for the quarter came in at $5.05 million, versus $6.15 million reported last year.

For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Lowe's slashes full-year sales outlook amid DIY spending pressure
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance